Antibody class switch recombination (CSR) occurs after antigen activation of B cells. CSR is directed to specific heavy chain isotypes by cytokines and B cell activators that induce transcription from the unrearranged, or germline (GL), C H region genes. Transforming growth factor (TGF)-β1 is essential for switch recombination to IgA due to its ability to induce transcription from GL Ig α genes. It has been shown that the promoters which regulate transcription of mouse and human GL α RNAs contain a TGF-β1-responsive element that binds Smad and core binding factor (CBFα)/AML/PEBPα/Runx. They also contain other elements which bind the transcription factors CREB, BSAP and Ets family proteins. In this manuscript we demonstrate that two tandem Ets sites in the mouse GL α promoter bind the transcription factors Elf-1 and PU.1, and that the 3Ј site is essential for expression of a luciferase reporter gene driven by the GL α promoter. Binding of Elf-1 to the GL α promoter is inducible by lipopolysaccharide in nuclear extracts from splenic B cells. An NF-κB site is identified, although it does not contribute to expression of the promoter in reporter gene assays. Since CSR to IgA is greatly reduced in NF-κB/p50-deficient mice, these data support the hypothesis that NF-κB has roles in switching in addition to regulation of GL transcription. Finally, we demonstrate that nocodazole, which disrupts microtubules that sequester Smad proteins in the cytoplasm, stimulates transcription from the GL α promoter.
Introduction
Upon antigenic or mitogenic stimulation, B lymphocytes prolifis a good correlation between the specificity of GL transcription and the specificity of the isotype switching events. erate and differentiate. As they proliferate, some of the progeny switch from expression of IgM to expression of Furthermore, targeted deletion of DNA segments containing the promoter and first exon (I exon) of a GL transcript other Ig classes. Ig heavy chain class switching allows the recombined variable (VDJ) region gene segment to be abrogates switching to that allele (2-5). Therefore, although the molecular mechanism of CSR is unknown, the data indicate expressed with a new downstream constant region (C H ) gene, resulting in a change in the effector function of the antibody.
that regulation of transcription of unrearranged C H genes is important for regulation of class switch recombination. Class switching is effected by a deletional recombination which occurs between switch region sequences located
In order to understand how switching to IgA is regulated, we are studying the regulation of transcription of GL α RNA. upstream of each C H gene. Class switch recombination (CSR) is directed to a particular C H gene by cytokines which induce Transforming growth factor (TGF)-β1 induces GL α transcripts in mouse splenic B cells activated by polyclonal activators, transcription from unrearranged, or germline (GL), C H genes before switch recombination to the same C H gene (1) . There e.g. lipopolysaccharide (LPS), and, subsequently, cells in this population will undergo switch recombination to IgA (6-9). Furthermore, Ets proteins often require protein partners in order to bind DNA and to activate transcription (31) . Similarly, in the I.29µ B lymphoma cell line, TGF-β1 increases
In this manuscript we compare the effects of nucleotide GL α transcripts and in the presence of LPS induces switching substitutions in all the transcription factor binding sites known to IgA (10). The induction of GL α transcripts by TGF-β1 in to be, or potentially, important for activating the mouse GL α this cell line was shown to be due to regulation at the promoter. We then focus our efforts toward identifying the Ets transcriptional level (10). Importantly, TGF-β1-deficient mice proteins that bind the GL α promoter in B cells and their role produce very little IgA (11) .
in transcription. We demonstrate that the Ets site is important TGF-β1 is a pleiotropic cytokine, having suppressive effects for TGF-β1 inducibility in addition to overall activity of the on growth, and both inhibitory and stimulatory effects on the promoter in I.29µ B cells. We show that although this site differentiation of a variety of cell types (12,13). Receptors for binds Fli-1 when present on a small DNA segment, it binds the TGF-β superfamily have serine/threonine kinase domains, Elf-1 and PU.1 in the context of the full-length promoter, and and treatment with TGF-β1 results in post-translational modithat Elf-1 binding is inducible in splenic B cell extracts by LPS. fication and activation of the transcription factors Smad 2 and It has been reported that mice with targeted deletions of Smad 3 (13-15). TGF-β1 also induces synthesis of other various NF-κB genes have defects in antibody class switching. transcription factors, i.e. AP-1 (16, 17) and core binding factor For some isotypes, e.g. IgE, the reduction in isotype produc-(CBFα) 3 (18) .
tion correlates with a defect in ability to synthesize GL To attempt to understand the regulation of transcription of transcripts (32, 33) . For IgA, it was found that NF-κB/p50-GL α RNA, DNA segments containing the 5Ј flank and first deficient mice produced 4-fold less IgA upon immunization initiation site of the transcripts have been analyzed by reporter (32) and that splenic B cells induced in culture switched~10-gene assays. A deletional analysis indicated that the DNA fold less well to IgA than wild-type B cells (33) . However, segment between -130 and ϩ46, relative to the first initiation Snapper et al. (33) found that there was no decrease in the site for mouse GL α transcripts, is sufficient for expression levels of GL α transcripts induced in the p50-deficient mice. and TGF-β1 inducibility of a reporter gene in two different B
In this manuscript we examine the effect of mutation of a cell lines (19). Within this region, a novel element (TβRE), NF-κB binding site on the activity of the GL α promoter. located at -128/-104 relative to the first RNA initiation site in the GL α promoter, was found to be required for TGF-β1 inducibility of a reporter gene and when multimerized was Methods sufficient to transfer the inducibility to a minimal c-fos promoter (19). This element, which is present in both the mouse and Cell lines human promoters, consists of a direct repeat unit containing Two mouse B lymphoma cell lines were used in this study: binding sites for two different transcription factor families: (i) I.29 µ (22D subclone), an sIgM ϩ B cell line which can be Smad and (ii) CBFα proteins (also known as Runx, AML or induced to undergo class switch recombination to IgA (34, 35) , PEBPα) (18, (20) (21) (22) (23) (24) (25) . Additional CBFα binding sites are also and A20.3, a sIgG2a ϩ B cell line which has not been present in the mouse and human GL α promoters (18, 23) . demonstrated to undergo class switching (36) . When activated by TGF-β1 treatment, Smads 3 and 4 synergize with CBFα to induce the GL α promoter (22, 24, 25) .
Cell culture Synthesis of one of the CBFα proteins, CBFα3, is inducible I.29µ cells were cultured as described (10). A20.3 cells were by TGF-β1 in splenic B cells and in the B cell line I.29µ (18) . cultured at 37°C in an atmosphere of 5% CO 2 in RPMI 1640 A binding site for an ATF/CREB transcription factor is also medium supplemented with 10% FBS, 50 µM 2-mercaptoimportant for expression and TGF-β1 inducibility of both the ethanol, 0.1 mM non-essential amino acids, 1 mM sodium mouse and human GL α promoters in reporter gene assays pyruvate, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml (19,26). Recently, CREB was shown to bind this site and to streptomycin and 0.1 mg/ml kanamycin sulfate (the last six synergize with Smads 3 and 4, and CBFα to confer TGF-β1 reagents came from Gibco, Grand Island, NY). In transfection inducibility to the mouse promoter when over-expressed (25) . experiments with I.29µ cells shown in Fig. 1 , human or porcine Surprisingly, the B cell-specific protein BSAP was found to TGF-β1 (R & D Systems, Minneapolis, MN) was added twice inhibit transcription when bound to a site in the GL α promoter (right after transfection and again at 7 h after transfection) at (27) , whereas it activates transcription from the GL ε proa concentration of 1 ng/ml each time. In experiments with moter (28, 29) .
A20.3 cells and in all other experiments with I.29µ, TGF-β1 An Ets site has been shown to be essential for expression was added right after transfection at a final concentration of of the human GL α promoter (26) , although which protein(s) 2 ng/ml. The amount of TGF-β1 used was determined to be functions through this site was not determined. The mouse in the optimal range (data not shown). promoter also has an Ets consensus element at a comparSplenic B cells were purified and cultured as described able position, although its function has not been previously (37) , except cells were cultured for 14 h with TGF-β1 (2 ng/ ml) and LPS (50 µg/ml). examined. Ets sites have a core GGA sequence, with most having a GGAA core, and additional nucleotides surrounding Oligonucleotides the core affect which particular Ets protein binds at a specific site (30) . However, since most cells have several different Ets The sequences of the top strand of the double-stranded proteins it is often difficult to determine which protein(s) oligonucleotides used in electrophoretic mobility shift assays (EMSA) are given below. actually binds and regulates transcription of particular genes. Mutations of the GL α promoter (Fig. 1A) were created by PCR based on an overlap extension technique (39) . PCRPrimers used for PCR. Lower case bold letters indicate mutated nucleotides; lower case plain text letters indicate amplified fragments carrying the desired mutations were then cloned into SmaI-BglII sites upstream of the luciferase (Luc) nucleotides used for cloning that are not in the GL α promoter. Reverse PCR primer (ϩ14/-7) 5Ј-cgcggatccTGGATGGGTCAreporter gene in the pXP2 vector (40) . Each construct was sequenced to confirm that the expected mutations had been GACTGAGCGC-3Ј; mEts, upper 5Ј-GGAACgatcgGTGGG-TGAGGGACC-3Ј; lower 5Ј-CCCACcgatcGTTCCACCTCCACintroduced and that no extra mutations had been created. DNA sequencing was performed using the dideoxy chain GTT-3Ј; mκB, upper 5Ј-TGGAACAGGAAGTGGGTcttctctagaACCTAGGGGCCAGAC-3Ј; lower 5Ј-GTCTGGCCCCTAtermination method with Sequenase version 2.0 kits (US Biochemical, Cleveland, OH) or by automated sequencing GGTtctagagaagACCCACTTCCTGTTCCA-3Ј; mCBF3, upper 5Ј-CCCACCTAGGtaaactaCACACAGTCATGCAG-3Ј; lower 5Ј-using an Applied Biosystems sequencer and software (Foster City, CA). agtttaCCTAGGTGGGGTCCC-3Ј; m(κB ϩ CBF3) upper 5Ј-tctagaACCTAGGtaaactaCACACAGTCATGCA-3Ј; lower 5Ј-agtttTransfection aCCTAGGTtctagagaaGACCCACTTCCTGTTCCA-3Ј.
Single-stranded oligonucleotides were obtained from Transfection was performed by electroporation using Cell ZapII (Anderson Electronics, Brookline, MA) as described Operon Technologies (Alameda CA), DNA International (18) . The GL α Luc reporter plasmids were co-transfected
In vitro transcription and translation with one of three different internal control plasmids, depending
For in vitro transcription and translation, hElf-1, hPU.1 and on the experiment. pSV2CAT was used for I.29µ transfections mFli-1 proteins were synthesized using the TNT-coupled shown in Fig. 1 identified in the promoter for mouse GL α transcripts. To assess their relative importance for TGF-β1 induction and for Luc, CAT and β-gal assays the overall level of expression of the promoter, nucleotide Luc and CAT assays were performed as described (37) , and substitution mutations were created in each of the known β-gal was assayed as described (49) . The CAT activity was binding sites within the -130/ϩ14 promoter segment ( active as the -128/ϩ46 segment used in previous experiments (19). The plasmids were transiently transfected into I.29µ (the Oligonucleotide probes for EMSA 22D subclone) and A20.3 B lymphoma cells. I.29µ (22D) To produce double-stranded oligonucleotides, complecells express surface IgM and constitutively express GL α mentary single-stranded oligonucleotides were annealed at transcripts, which can be further induced by treatment with 100 ng/µl each in 100 mM NaCl, 10 mM Tris-HCl, pH 8.0 TGF-β1 (10). A20.3 cells express sIgG2a and have no detectand 1 mM EDTA. Prior to annealing, the oligonucleotides were able GL α transcripts when cultured with or without TGF-β1, incubated at 95°C for 10 min to disrupt secondary structure, although they have C α genes (19). The plasmid pSV2CAT, and then incubated at 10°C below the T m for 1 h and slowly which expresses the CAT gene under control of the SV40 cooled to room temperature. The annealed oligonucleotides enhancer/promoter, was co-transfected in these experiments were ethanol precipitated and purified on a 12-15% polyas an internal control for variation in transfection efficiency. acrylamide gel. Purified double-stranded oligonucleotides In I.29µ cells, TGF-β1 increases Luc activity of the plasmid were end-labeled with [γ-32 P]ATP using T4 polynucleotide driven by the wild-type GL α promoter by 3.5-fold (Fig. 1B) . kinase. DNA segments corresponding to the GL α promoter This level of induction is consistent with previous results (19). from -130 to ϩ14 were generated by PCR. They were gelThese results are also in accord with the finding that TGF-β1 purified and end-labeled as described for the annealed increases transcription of the endogenous GL α RNA in I.29µ oligonucleotides.
cells by 5-fold in a nuclear run-on assay (10). The DNA segment -130/-104 contains a direct repeat Preparation of nuclear extracts (NE) dimer that has two binding sites for Smad proteins (CAGAC, indicated as SBE1 and 2, Smad-binding element, in Fig. 1A ) NE for I.29µ, A20.3 and splenic B cells were prepared using the method of Schreiber et al. (50) as modified (37) . In and two binding sites for CBFα (ACCACA, indicated as CBF1 and 2). This segment has been shown to be sufficient for addition to several protease inhibitors, a phosphatase inhibitor Na 3 VO 4 (Boehringer Mannheim, Indianapolis, IN) was added conferring TGF-β1 responsiveness to a minimal c-fos promoter (19), and to be synergistically activated by Smads 3 and 4 to buffer A and C at a final concentration of 1 mM. Protein concentration of the NE was determined using the Bradford and CBFα (18, (22) (23) (24) . Mutation of SBE 1 and 2 in construct m1-TβRE eliminates TGF-β1 induction but does not reduce assay (BioRad, Richmond, CA).
basal activity in I.29µ cells (Fig. 1A and B) . Mutation of CBF1 and 2 (m2-TβRE) reduces TGF-β1 induction by~30% and basal promoter activity by~50%. Mutation of a downstream, weak CBFα binding site (CBF3) (18) reduces basal activity by 3-fold but has no effect on TGF-β1 induction. Consistent with published studies (18, 24, 25) , mutation of the CREBbinding site eliminates induction by TGF-β1 and reduces basal promoter activity by 5-fold.
Surprisingly, mutation of a sequence element that matches a consensus NF-κB binding site (-54/-45) slightly increases promoter activity and has no effect on induction by TGF-β1. This site does bind NF-κB/p50 (see below). Two additional sets of mutations of the κB site were also tested in the reporter assay with similar results (data not shown). Mutation of both the κB element and the third CBFα binding site has an effect similar to mutation of the third CBFα site alone (Fig. 1B) . Of all the sites in the promoter, the Ets consensus motif at -64/- The effects of the promoter mutations were similar but A pCMV-β-gal reporter plasmid was co-transfected for normalization not identical when tested in A20.3 cells (Fig. 1C) . TGF-β1
for transfection efficiency. The data were obtained from three increases Luc activity of the wild-type promoter by 8-fold in experiments and the error bars show the SEM.
A20.3 cells. Mutation of both SBEs (m1-TβRE) abolishes induction and reduces basal promoter activity by 60%. Mutation of the ATF/CRE or Ets site nearly eliminates promoter activity, although TGF-β1-induction is mostly retained. As in expression plasmid for a dominant-negative version of Ets2 (47) along with the GL α promoter Luc reporter plasmid in I.29µ cells, mutation of CBF3 reduces expression but has no effect on induction by TGF-β1 (data not shown) and mutation A20.3 cells. As shown in Fig. 2 , the dominant-negative Ets2 expression plasmid inhibits the basal expression and also of the κB site has little effect on promoter activity. As in I.29µ cells, the effect of mutation of both the κB site and CBF3 is TGF-β1 induction of the promoter in a dose-responsive manner. The recombinant dominant-negative Ets protein was similar to the effect of mutation of CBF3. Unlike results in I.29µ cells, however, the m2-TβRE mutation does not shown to bind to the GL α Ets site in EMSA (data not shown). These data further indicate the importance of Ets family significantly affect promoter activity (15% reduction for TGF-β1-induction and 10% reduction for basal activity compared proteins for activity of the promoter. with the wild-type promoter, data not shown). In both cell
Identification of Ets proteins binding to the GL C α promoter lines, TGF-β1 has no effect on the promoterless pXP2 plasmid.
Thus, the effects of mutation of some of the consensus Since a consensus Ets element is essential for expression of the GL α promoter, it was important to identify the Ets proteins elements differ somewhat between two cell lines, only one of which (I.29µ) can express endogenous GL α transcripts and which bind this site. In addition to the Ets site at -64/-61 indicated in Fig. 1(A) , there is another consensus Ets site switch to IgA. In both cell lines, the SBE are necessary for inducibility by TGF-β1. However, the CBFα-binding sites 1 just upstream at -70/-67. There does not appear to be a counterpart for this upstream Ets site in the human and rabbit and 2 differ in their importance in the two cell lines, being important for both basal and induced expression in I.29µ but promoters (51,52). Using EMSA, we tested binding of nuclear proteins from TGF-β1-treated I.29µ cells to a 17 bp GL α not in A20.3 cells. This may be because TGF-β1 induces CBFα3 in I.29µ cells but not in A20.3 cells (18) , although the DNA segment, -71/-55, that contains the two core Ets sites. Figure 3 (A) presents the sequences of the probe with the two constitutively expressed CBFα2 is equally abundant in these two cell lines (unpublished data). In I.29µ cells the ATF/CREB core Ets sites underlined. The core of the 5Ј site is present in this probe, but since a functional Ets site includes 5 element is essential for induction by TGF-β1 and the Ets motif is essential for all promoter activity, whereas in A20.3 these nucleotides upstream of the core sequence this site is incomplete. The 3Ј Ets site is the site mutated in the reporter gene elements are do not contribute to TGF-β1 inducibility although they are very important for overall promoter activity. Neither assays shown in Fig. 1 . As shown in Fig. 3(B) , two complexes are formed with this probe which can be competed by a CREB nor Ets proteins have been reported to be inducible by TGF-β1. The data obtained in I.29µ cells are consistent 10-fold excess of the probe (Fig. 3B, lane 3) but not by double-stranded oligonucleotides containing a mutated Ets with the hypothesis that CREB and the protein(s) binding at the Ets site interact directly, or indirectly, with the TGFor wild-type κB site (Fig. 3B, lanes 4 and 5) . Antibody supershift assays shown in Fig. 3 (C, lanes 9, 11 and 13) β1-inducible proteins, Smads and CBFα3, which bind at the TβRE.
reveal that the Ets protein Fli-1 forms the faster migrating complex. Components of the other complexes have not been To further establish the importance of the Ets site for activity of the promoter, we tested the effect of co-transfection of an identified and it is unknown if the two additional complexes formed with this probe, which are seen quite clearly in Fig.  (data not shown) . TGF-β1 treatment has no effect on formation of the Ets complexes (Fig. 3C , cf. lanes 7, 8 and 15, 16; data 3(C) but barely in Fig. 3(B) , are specific. Antibodies to two other Ets proteins, Elf-1 and PU.1, do not affect the complexes not shown). NE from A20.3 cells gave similar results, except they have slightly lower levels of Elf-1 binding activity (data formed with this probe (Fig. 3C, lanes 10, 12 and 14) .
Surprisingly, when a DNA probe containing the full-length not shown). These data indicate that the binding of Elf-1 and PU.1 to promoter used in the reporter assays is tested in the antibody supershift assays, we find that Fli-1 antibody does not affect the GL α promoter requires, in addition to the -71/-55 segment, the flanking region. Neither of the two Ets consensus the complexes, whereas Elf-1 antibody supershifts the predominant slowest migrating complex (Fig. 3D, lanes 21-24) .
elements in the GL α promoter are optimal Elf-1 or PU.1 sites. An optimal Elf-1 site is shown in Fig. 3(A) (44,53) . It has The Ets site mutation used in the reporter gene assays shown in Fig. 1 eliminates Elf-1 binding (Fig. 3E, cf. lanes 1 and 7) .
previously been shown that Elf-1 binds to and activates transcription at non-optimal sites by interacting with other A DNA probe of intermediate length, containing the -94/-55 promoter segment, binds both Fli-1 and Elf-1, as proteins, including AP-1, HMG-I(Y) and NF-κB p50 and c-Rel (54-56). However, we have not found any binding sites for both of these antibodies supershift complexes (Fig. 3C, lanes  17-19) . In addition, PU.1 antibody inhibits the fastest migrating AP-1 or HMG-I(Y) in the GL α promoter and the NF-κB site is not required for promoter activity. Although Fli-1 binds to the complex formed with the -94/-55 probe and inhibits a component of the fast-migrating major complex formed with the small probe, it too may have a partner protein since the Fli-1 complex formed on the small probe migrates slightly more full-length promoter segment (Fig. 3C, lane 20 and Fig. 3D , lane 25) . No other Ets antibody tested (Ets1/2, PEA3 and slowly than the complex formed with the -94/-55 probe (Fig.  3C , cf. lanes 14 and 15). Perhaps the partner proteins differ SpiB) affected complexes detected with any GL α probe on these two probes.
Sequences required for Elf-1 and PU.1 binding to the GL α promoter.
To attempt to identify the nucleotides required for binding of Elf-1 and PU.1 to the GL α promoter, several probes of different lengths were tested in EMSA using I.29µ NE. Addition of 4 nucleotides to the 5Ј side of the Ets sites (-75/-55 segment) did not allow Elf-1 binding (data not shown). Addition of 4 nucleotides to the 3Ј side (-75/-51) only allowed weak Elf-1 binding (data not shown). By testing several additional segments, we found that the nucleotides required for nearly optimal Elf-1 binding resided within the -83/-51 segment. This probe also binds PU.1. It also binds Fli-1, but to a lower extent than the -71/-55 probe (Fig. 4 , lanes 1-7, and data not shown).
To further explore the sequence requirements for Elf-1 and PU.1 binding, we created single-or double-nucleotide mutations in the -83/-51 probe. Consistent with a previous report (57), mutation of a single A within the 3Ј Ets site to T nearly eliminates Elf-1 binding but increases PU.1 binding, Fig. 3 . EMSA demonstrate that Elf-1 and PU.1 bind the intact GL α promoter. (A) Nucleotide sequences of the wild-type and mutant oligonucleotides used in EMSA and in reporter gene assays, and the optimal consensus Elf-1 binding sequence (44, 53) . (B) Competition EMSA using 2 µg NE from I.29µ cells treated with TGF-β1 for 14 h and the GL α -71/-55 segment as probe. The left-most lanes in (B)-(D) contain the probe alone. Competitor DNA segments are the wild-type -71/-55, a -71/-55 segment containing the same Ets mutation (mEts) as shown in Fig. 1(A) and a wild-type consensus κB (NF-κB binding site) oligonucleotide (see Methods). (C) Supershift EMSA using 2 µg NE from I.29µ cells, untreated or treated with TGF-β1 for 14 h incubated with the -71/-55 or -94/-55 promoter segment, as indicated. (D) Supershift EMSA using 2 µg of NE from TGF-β1-treated A20.3 cells and the wild-type -130/ϩ14 full-length promoter segment used in the reporter gene assays shown in Fig. 1. (E) EMSA demonstrate that NF-κB/p50 binds the GL α promoter. Competition and supershift EMSA using the -130/ ϩ14 promoter segment with wild-type or mEts sites and 2 µg NE from TGF-β1-treated I.20µ cells. For competitions with the wild-type probe, the κB, CRE (CREB-binding site), Elf-1 and CBFα oligonucleotides were used at 500-fold excess, and the AP-1 oligonucleotide at 100-fold excess. For competitions with the mEts probe, the competitors were used at 50-fold excess except AP-1 was used at 90-fold excess. Supershift EMSA were performed with NE from TGF-β1-treated I.29µ cells or from and LPS ϩ TGF-β1-treated splenic B cells, as indicated. An aliquot of 1 µl of antibody (Santa Cruz Biotechnology) was used in each reaction, unless indicated otherwise. does in B cell NE. Also, although recombinant PU.1 does bind the short probe, it does not bind as well to the short probe as to the longer probe. Since the recombinant Elf-1 complex co-migrates with the complex formed with I.29µ NE (Fig. 5, lanes 14-16) , it appears that if a partner protein is indicate that although Elf-1 and Fli-1 bind in a reciprocal manner to the various Ets site probes, this is not simply due to Fli-1 competing with Elf-1, since when recombinant Elf-1 is suggesting that PU.1 binding does not depend on Elf-1 tested individually, it shows the same binding specificity. binding (Fig. 4, lanes 11-13) . Mutation of nucleotides -69/-Effect of Elf-1 binding on activity of the GL α promoter 68 in the 5Ј Ets site eliminates PU.1 binding and greatly decreases Elf-1 binding, suggesting that the 5Ј Ets site is To provide further evidence for the importance of specific Ets also important for binding of both these proteins (Fig. 4, lanes proteins for activity of the GL α promoter, we tested the 15-17). To attempt to identify other proteins which bind the effects of two of the single nucleotide mutations in the reporter -83/-51 probe and might help Elf-1 binding, several sets of gene assay. Since the EMSA data shown in Fig. 4 indicate mutations were created in nucleotides flanking the two Ets that the A at -61 is essential for binding of Elf-1 and PU.1 to sites. Although all the flanking nucleotides were mutated the promoter, we tested the effect of this single mutation in in various combinations in these experiments, these other A20.3 cells. As shown in Fig. 6(A) , mutation of nucleotide mutations had only a small, or no, effect on Elf-1 binding -61 greatly reduces basal and TGF-β1-induced promoter (data not shown). It is possible that the particular mutations activity, but not TGF-β1 inducibility, similar to the effect of chosen do not prevent binding of a putative partner protein mutation of the entire Ets core site (mEts) in A20.3 cells shown or that the partner protein binds non-specifically.
in Fig. 1(C) . To attempt to determine if the promoter specifically To examine whether binding of Elf-1 to the wild-type GL α requires Elf-1 for activity, we examined whether mutation -66, promoter depends on B cell-specific proteins, we asked if which nearly eliminates Elf-1 binding but increases PU.1 individual recombinant Elf-1, Fli-1 and PU.1 obtained by binding, would have an effect on transcriptional activity of in vitro translation using reticulocyte lysates would show the -130/ϩ14 promoter in I.29µ cells. m-66 was found to the same binding specificity as found in B cell extracts.
reduce basal and TGF-β1-induced Luc activity by 2-fold (Fig. Reticulocyte lysates programmed by mRNA for the three 6B). These results suggest that even when the binding of different Ets proteins were used in EMSA with both the shorter PU.1 is enhanced, PU.1 cannot completely substitute for Elf-1. and longer GL α Ets probes. Figure 5 shows that the short Activation of the GL α promoter by transcription factor expresEts probe, -71/-55, binds recombinant PU.1 and Fli-1 but sion plasmids fails to binds Elf-1 (Fig. 5, lanes 3-7) , whereas the -83/-51 probe binds all three proteins (Fig. 5, lanes 8-13) . Thus, Since the EMSA data indicate that Elf-1 binds the GL α promoter, we wished to test if co-transfection of an expression recombinant Elf-1 binding retains the same specificity as it plasmid for Elf-1 would increase activity of the promoter in reporter gene assays. Expression plasmids for transcription factors known to be important for TGF-β1-induced expression of this promoter were also included to determine if Elf-1 might cooperate with them. As shown in Fig. 7(A) , in I.29µ cells over-expression of CBFα3 or the combination of Smads 3 and 4 increases both the basal and TGF-β1-induced Luc activity relative to empty expression plasmids, although the addition of all three factors does not further enhance activity. Addition of Elf-1 to the combination of Smads 3 and 4 and CBFα3 does, however, further increase promoter activity.
We also tested the effect of over-expression of these transcription factors in A20.3 cells (Fig. 7B) . It can be seen that, as reported previously (22) and unlike results obtained in I.29µ cells, Smads 3 and 4 synergize with CBFα3 to activate the promoter in A20.3 B lymphoma cells. However, in these cells Elf-1 does not further increase promoter activity. For unknown reasons, it is generally difficult to obtain increased transcriptional activity by over-expressing Ets proteins. This may be due to limiting amounts of a cooperating factor, since it has been reported that Elf-1 activity at non-optimal Elf-1 sites requires cooperation with partner proteins (53, 55 ). Although we have tested PU.1, CREB, HMG-I(Y), NF-κB and p300, we have been unable to identify any proteins that synergize with Elf-1 to activate transcription from the promoter (data not shown).
Elf-1 binding is affected by LPS activation of splenic B cells
The above data suggest that Elf-1 or PU.1 binding is required for transcription of the GL α promoter in B cell lines. Therefore, it was important to determine if NE from splenic B cells activated to switch to IgA contain Elf-1 or PU.1 binding activity. Using the -130/ϩ14 promoter segment in EMSA, we found that NE from resting splenic B cells do not show Elf-1 binding activity, but that after activation for 14 h with LPS alone, or with LPS ϩ TGF-β1, binding activity is induced (Fig. 8, cf . lanes 2, 3 and 5, 6; data not shown). PU.1 binding to the promoter was not detected. Induction of Elf-1 activity may be one of the roles of LPS in activating class switching in splenic B cells. However, LPS has additional roles since it is required for induction of CSR in I.29µ cells (10), although it is not required for Elf-1 binding activity in these cells (Fig. 8, lanes  8 and 11) . undergo class switching to certain isotypes when activated TGF-β1 was added right after transfection at 2 ng/ml. Luc activity in culture or by immunization (32, 33) . NF-κB has been shown was assayed 12 h after transfection. Means ϩ SEM from three to be important for expression of GL transcripts for some independent experiments are reported in light units after subtraction of background (no cell extract) of 200-300 light units. Variation of isotypes and this may be the explanation for the inability of transfection efficiency among different plasmids was corrected by p50-deficient B cells to switch to these isotypes. Although it the activity of β-gal expressed from co-transfected pCMV-β-gal. (B) has been shown that p50-deficient B cells switch poorly to Luc activities from the identical experiment performed in A20.3 cells IgA, they express normal levels of GL α transcripts. Consistent (n ϭ 4), except that 2 µg of expression plasmids was used and with these published data, mutations within the NF-κB concells were harvested for the Luc assay at 16 h after transfection. sensus binding element in the GL α promoter do not reduce its activity in the reporter assay (Fig. 1B and C) .
Because of this result it was important to demonstrate that the consensus κB element actually binds NF-κB. In the EMSA fastest-migrating predominant complex (Fig. 3E, lane 2) , and also competes with this complex and an additional slowershown in Fig. 3(E) , using the -130/ϩ14 probe, we demonstrate that a consensus κB site competes a component of the migrating complex detected using the mEts site probe and HeLa cells lines (58) . TGF-β1 treatment of an epithelial cell line results in the release of Smads from microtubules, and subsequent phosphorylation and migration to the nucleus (Fig. 3E, lane 8) . Presumably, the faint upper NF-κB complex where they activate transcription. Dong et al. (58) were able also binds the wild-type promoter segment but cannot be to mimic and enhance the effect of TGF-β1 on transcription detected due to the background at this position in the lane.
by treatment of the epithelial cell line with nocodazole, which To determine whether these two complexes contain NF-κB/ disrupts microtubules. We were interested to learn if Smad p50, supershift assays were performed, as shown in Fig. 3 (E, proteins might also be associated with microtubules in B cell lanes 12-17). Using the -130/ϩ14 probe, anti-p50 supershifts lines, so we tested whether nocodazole could stimulate a component of the fastest-migrating major component transcription driven by the GL α promoter in a B cell line. detected with NE from I.29µ cells (Fig. 3E, lane 13 ) and also Consistent with the results in epithelial cells, we found that from LPS ϩ TGF-β1-treated splenic B cells (Fig. 3E, lane 15) .
nocodazole increases activity of the promoter in A20.3 B cells Using the mEts probe in supershift experiments with antibody by 2-to 3-fold, in the presence or absence of TGF-β1, and to NF-κB p50, we find that both complexes are supershifted also when Smads 3 and 4 are over-expressed (Fig. 9) . These (Fig. 3E, lane 17) . data suggest that in the absence of TGF-β1, transiently We reasoned it was possible the κB mutations do not affect transfected Smad proteins associate with microtubules in B activity of the GL α reporter plasmid because the amount of cell lines, e.g. A20.3, and that TGF-β1 disrupts this association. NF-κB is too low in the B cell lines to activate the promoter. To examine this possibility, we tested the effect of overexpression of several NF-κB proteins in co-transfection Discussion reporter gene assays. None of the expression plasmids An Ets site is essential for expression of the GL α promoter tested, those encoding p50 alone, or RelA, c-Rel or RelB in combination with p50 stimulated GL α promoter activity in
In this study we compared the effect of mutation of several transcription factor binding sites on expression and TGF-β1 I.29µ cells (data not shown). We conclude that although NF-κB can bind the GL α promoter, it does not have a induction of the mouse GL α promoter. We demonstrated that an Ets site is essential for expression of this promoter and significant effect in transient reporter gene assays. also for its inducibility by TGF-β1 in I.29µ cells. This site binds Nocodazole treatment increases GL α promoter activity Elf-1 and PU.1 in the context of the full-length promoter used in transfection experiments. We also demonstrated that one Smads 2, 3 and 4 have recently been shown to be associated with microtubules in the cytoplasm of epithelial, endothelial of the several CBFα binding sites located 3Ј to the direct repeats of the TβRE contributes to expression of the promoter 50% in A20.3 cells. Furthermore, extensive gel shift and Western blotting analyses failed to find evidence that TGF-β1 in reporter assays, but that a nearby NF-κB-binding site does not. Finally we showed that nocodazole, an inhibitor induces Ets proteins in the two B cell lines or in splenic B cells ( Fig. 3 and data not shown) . Because of these data, we of microtubule formation, stimulates promoter activity. As previously shown for endothelial and epithelial cell lines (58) , hypothesize that Ets proteins, presumably Elf-1 and PU.1, may interact with complexes involving TGF-β1-induced factors this last finding suggests that Smad proteins are sequestered in the cytoplasm via an association with microtubules in B and thereby contribute to TGF-β1 induction of the promoter.
Candidates for this interaction are the TGF-β1 inducible cell lines.
Ets proteins have been implicated in regulation of genes factors that bind the GL α promoter, i.e. Smads 3 and 4 and CBFα3. This complex might also involve CREB, since this during a variety of biological processes, including growth control, transformation, lymphocyte differentiation and develfactor also contributes to TGF-β1 induction of the promoter (Fig. 1B) (71, 72) . Elf-1 binding activity has been shown (30, 55, 70) . However, although the Ets and κB sites in the GL α promoter are also near each other, they do not appear to to be dependent upon serine phosphorylation and many of the phosphorylated serine residues match consensus MAP cooperate in that the Ets site is essential and the κB site appears to have no role in transcriptional activity. By contrast, kinase sites (30) . PU.1 can also be phosphorylated on serine by JNK1 and by casein kinase II in vitro, and is phosphorylated CBFα, another protein known to interact with Ets proteins, is important for TGF-β1-induced activity of the GL α promoter.
in B cells. However, no functional significance for PU.1 phosphorylation has been demonstrated (30). Consistent with a requirement for cooperative binding with another transcription factor, the Ets sites of the GL α promoter In addition to being regulated by phosphorylation, Elf-1 activity is regulated by binding to the cell-cycle regulator Rb. bind Elf-1 and PU.1 when the probe used for EMSA contains at least 13 nucleotides 5Ј and 10 nucleotides 3Ј to the core Elf-1 binds to the hypophosphorylated form of Rb protein, but not the phosphorylated form (73) . During the transition from Ets elements (GGAA). However, if a short fragment containing 7 nucleotides upstream and 6 nucleotides downstream of the the G 1 to S phase of the cell cycle, Rb becomes phosphorylated, and the DNA binding and transcriptional activities of 3Ј Ets core is used as a probe, Fli-1 binds but not Elf-1 or PU.1. These data indicate that nucleotides in addition to the Elf-1 are induced in peripheral blood T cells. Since LPS induces kinase activity and B cell proliferation, it is possible 3Ј Ets site are required for Elf-1 and PU.1 binding. Recombinant Elf-1 and PU.1 tested individually in EMSA retain the same that LPS induces Elf-1 activity by two mechanisms, by serine phosphorylation and by dissociation from Rb. CSR in splenic binding specificity, indicating that the differential binding is not due to competition among these Ets proteins for the same B cells requires cell proliferation (74) and during this proliferation Elf-1 may be activated. Furthermore, IgA switching in vivo binding sites. From these data we conclude that Elf-1 and PU.1 are likely to be the proteins which bind in vivo. The occurs in the highly stimulatory environment of the intestinal lymph tissue called Peyer's patches, in which B cells are binding differences may be due to the requirement for additional binding sites for different partner binding proteins.
rapidly proliferating (75,76). The bacterial products endotoxin, non-methylated CpG-containing DNA and other bacterial However, we have tested the effect of mutating several different nucleotides in the flanking regions of the -83/-51 cell wall components within this environment induce B cell activation and proliferation (77, 78) . Our data suggest that Ets probe on binding by Elf-1 and PU.1, and find that the only mutations that significantly reduce binding are those induction of Elf-1 binding after activation of B cells during an immune response is important for GL α transcription and within or between the two Ets sites (Fig. 4 and data not  shown) . Therefore, we have been unable to obtain direct data subsequent switching to IgA. implicating interactions between these Ets proteins and other NF-κB binds to the GL α promoter but has no effect on its transcription factor families in the regulation of the GL α activity in transient transfection reporter assays promoter.
Although we obtained no direct evidence of protein-protein The finding that mutation of the NF-κB binding site has no effect on activity of the GL α promoter in reporter gene assays interaction, our reporter gene assays suggest that Ets proteins which bind the GL α promoter interact with other factors to was surprising, although this finding is consistent with results showing that p50-deficient B cells synthesize normal levels regulate the TGF-β1-inducible and constitutive activity of the promoter. Mutation of the more 3Ј Ets site not only eliminates of GL α transcripts (33) . NF-κB sites have been found in the promoters for three other mouse IgH GL transcripts: ε (29,79), basal expression but also eliminates TGF-β1 inducibility of the GL α promoter in I.29µ cells. In addition, over-expression γ1 (37) and γ3 (80). These κB sites have been shown to be essential for expression of the GL ε and γ1 promoters, and of a dominant-negative form of Ets 2 only inhibits basal activity of the promoter by 30%, but inhibits TGF-β1 inducibility by for their induction by IL-4 and/or by CD40L (29,37,79,81). 
